Nanion Opens US-office in New Jersey
News Feb 18, 2009
Nanion announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support the increasing demand of Nanion's products, and to continue giving customer service, Nanion now expands its presence in the American market.
Nanion opens the doors to the US-office in North Brunswick, NJ. Nanion Technologies Inc. has a fully equipped demonstration and service center for North America, supporting the Port-a-Patch and the Patchliner, and from the end of the year, the SyncroPatch 96. Nanion's demonstration site is located in Chromocell's newly built laboratory space. Nanion and Chromocell, a leader in the creation of previously inaccessible drug targets, are engaged in a research partnership.
"With the rapidly growing number of American customers, we need to increase our efforts in the North American market which will strengthen our position as a leading provider of sophisticated and high quality ion channel screening devices. Additionally, swift and competent technical support is very important to us and has always been our trademark. To expand and support the sales in the US , our US-office will make it easier for people to visit us and see our platforms in action." says Dr. Niels Fertig , CEO of Nanion Technologies.
Rodolfo Haedo, General Manager and Chief Application Scientist, recently joined the Nanion team to support the US customers from the headquarters in North Brunswick. Mr. Haedo has extensive electrophysiology background and valuable experience of various automated patch clamp platforms. Rodolfo Haedo was previously employed at Merck, Rahway, NJ where he was member of Merck's well renowned ion channel group.
"Rodolfo Haedo's background in automated electrophysiology is impressive and he is a very good fit for Nanion, especially since we now are in the phase of introducing the SyncroPatch 96, our HTS patch clamp platform. We are very happy to welcome him on board and look forward to a very exciting year!" continues Dr. Fertig.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
This Seed Could Bring Clean Water to MillionsNews
Biomedical Engineering and Chemical Engineering Professors Bob Tilton and Todd Przybycien recently co-authored a paper with Ph.D. students Brittany Nordmark and Toni Bechtel, and alumnus John Riley, further refining a process that could soon help provide clean water to many in water-scarce regions. The process, created by Tilton’s former student and co-author Stephanie Velegol, uses sand and plant materials readily available in many developing nations to create a cheap and effective water filtration medium, termed “f-sand.”READ MORE